Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-10-22
|
pubmed:abstractText |
Extended-spectrum beta-lactamase (ESBL) production among members of the family Enterobacteriaceae generally involves resistance to oxyimino-cephalosporins and monobactams, while implying different susceptibility profiles with other antimicrobial agents. We have investigated the activity of some beta-lactam antibiotics, alone or in double and triple combinations with beta-lactamase inhibitors, in the presence or absence of tobramycin (TOB), against some Enterobacteriaceae producing ESBL by means of time-kill curves. Antimicrobials employed were ceftazidime (CAZ), cefotaxime (CTX), TOB, ampicillin (AMP), ampicillin-sulbactam (ASL), amoxicillin (AML), amoxicillin-clavulanic acid (AMC), piperacillin (PIP) and piperacillin-tazobactam (TZP), at 1/4 minimum inhibitory concentration for susceptible strains and at achievable serum concentrations for resistant strains. Only the combinations CTX-ASL, CAZ-ASL and PIP-ASL were synergistic, both at 6 and 24 h, on some strains of Klebsiella species.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-3157
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-7
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:9732145-Anti-Bacterial Agents,
pubmed-meshheading:9732145-Drug Therapy, Combination,
pubmed-meshheading:9732145-Enterobacteriaceae,
pubmed-meshheading:9732145-Humans,
pubmed-meshheading:9732145-Klebsiella,
pubmed-meshheading:9732145-Microbial Sensitivity Tests,
pubmed-meshheading:9732145-Tobramycin,
pubmed-meshheading:9732145-beta-Lactam Resistance,
pubmed-meshheading:9732145-beta-Lactamases,
pubmed-meshheading:9732145-beta-Lactams
|
pubmed:articleTitle |
Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some enterobacteriaceae producing extended-spectrum beta-lactamases.
|
pubmed:affiliation |
Cattedra di Chemioterapia, Università di Pavia, Pavia, Italia.
|
pubmed:publicationType |
Journal Article
|